ÂÜÀòÂÒÂ×

David V. Smith is the chief financial officer and the executive vice president of Five Prime Therapeutics, Inc. Previously, he was the chief operating officer of IntegenX, a privately held company focused on rapid DNA identification technology. In his past career, he was the executive vice president and CFO of Thoratec Corporation, vice president and CFO at Chiron Corp., vice president and CFO of Anergen, Inc., and held various financial management positions with Genentech, Inc., IBM Corporation, and Syntex Corporation. Smith previously served as a member of the board of directors of OncoGenex Pharmaceuticals Inc., a public biotechnology company. He received an M.B.A., in Finance from Golden Gate University and a B.A. in Economics and History from Willamette University.